GEP44 was developed based on extensive structureactivity relationship studies and earlier preliminary in vivo studies that demonstrated its greater efficacy at reducing both food intake and body weight compared to the agonist peptide, Ex-4, without triggering gastrointestinal distress (as assessed by kaolin intake and behavioral scoring as a proxy for nausea in rats and direct evidence of emesis in shrews) 16
The TRIUMPH-4 results offer a glimpse into how multi-targeted peptide mechanisms might shape future metabolic support strategies
The Honest Evidence Gap Summary The core claim of the sermorelin-plus-GHK-Cu stack is that systemic GH/IGF-1 restoration and local copper-tripeptide tissue signaling work better together than either does alone
Your prescription and the vial labeling are the authority here
Lane TF, Iruela-Arispe ML, Johnson RS, Sage EH
Many individuals who have lost a significant amount of weight, especially those who have used medications, might have lost weight quite quickly, which can result in areas of loose skin